Curie.Bio is a founder-focused, early-stage venture firm and industry-grade therapeutics accelerator dedicated to helping entrepreneurial founders launch viable therapeutics companies. The company provides access to a team of top drug hunters and makers, seed capital, and essential services to facilitate the journey from concept to compelling datasets that enable successful Series A financing. Curie.Bio manages two funds: the Seed Fund, which advances therapies through preclinical milestones, and the Breakout Fund, which supports the progression of medicines through clinical trials. With a flat organizational structure, Curie.Bio emphasizes collaboration and aims to empower founders to focus on their expertise while the company handles the operational aspects of drug development.